ImPACT

Ofatumumab in chronic inflammatory demyelinating polyradiculoneuropathy associated with monoclonal gammopathy of undetermined significance: a case report

Study Overview The case report presents a detailed examination of a patient diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in […]

Ofatumumab in chronic inflammatory demyelinating polyradiculoneuropathy associated with monoclonal gammopathy of undetermined significance: a case report Read Post »

Mineralocorticoid receptor antagonists in dialysis patients after ACHIEVE and ALCHEMIST: updated systematic review and meta-analysis of 14 randomized trials

Mineralocorticoid receptor antagonists in dialysis patients after ACHIEVE and ALCHEMIST: updated systematic review and meta-analysis of 14 randomized trials

Study Overview The recent systematic review and meta-analysis evaluated the effectiveness of mineralocorticoid receptor antagonists (MRAs) in dialysis patients, drawing

Mineralocorticoid receptor antagonists in dialysis patients after ACHIEVE and ALCHEMIST: updated systematic review and meta-analysis of 14 randomized trials Read Post »

Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis

Study Overview The research focuses on chronic inflammatory demyelinating polyneuropathy (CIDP), a neurological disorder characterized by progressive weakness and sensory

Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis Read Post »

Scroll to Top